Testing different doses of propranolol for ulcerated hemangioma in children.
Treatments studied
Part of Cancer clinical trials.
This trial tests different starting doses of oral propranolol to see which works best and is safest for treating infantile hemangiomas that have ulcers (sores). It may help your child heal faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child has a hemangioma (a red birthmark made of extra blood vessels) that is ulcerated (has an open sore)
- Your child is being treated with propranolol by mouth
- Your child has not had other treatments for this ulcerated hemangioma
- Your child can take oral propranolol and does not have a condition that makes it unsafe, like a very slow heartbeat, asthma, or an allergy to propranolol
- Your family is willing to participate and follow the study plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of stopping propranolol in children with infantile hemangioma (a type of birthmark): stopping suddenly versus slowly reducing the dose. It aims to find out which method is safer and better at preventing the birthmark from growing back.
This study looks at babies with a common birthmark called infantile hemangioma (made of blood vessels) to help doctors decide the best treatment or whether monitoring is enough. It involves a first evaluation and follow-up, but no new drugs or procedures are tested.
This trial studies whether propranolol, a beta-blocker medicine, can help people with VHL who have non-urgent hemangioblastomas in the brain/spinal cord. It aims to see if the medication is safe and beneficial without needing immediate surgery.
This trial tests whether giving propranolol by mouth to certain very premature babies with early eye changes can stop retinopathy of prematurity from getting worse. It may help reduce the need for eye treatments later on.
This trial tests a cream containing simvastatin, a cholesterol medicine, applied to infantile hemangiomas (strawberry birthmarks) in babies aged 3-6 months. It may help shrink the birthmark without needing stronger treatments.
This trial tests if taking a medicine called propranolol around the time of surgery can improve outcomes for people with stomach or colon cancer that can be removed with an operation. Propranolol is a type of drug that blocks certain stress signals in the body and may help with recovery.
Hear when a new Infantile Hemangioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.